{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:41:11Z","timestamp":1792788071078,"version":"4.5.0"},"reference-count":242,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Zhengzhou University 2025 Undergraduate Innovation Training Program Projects","award":["202510459059, S202510459114, 2025cxcy786, 2025cxcy890"],"award-info":[{"award-number":["202510459059, S202510459114, 2025cxcy786, 2025cxcy890"]}],"id":[{"id":"https:\/\/ror.org\/04ypx8c21","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04444-7","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T19:43:30Z","timestamp":1786563810000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting the Notch signaling pathway in digestive system cancers: from bench to bedside"],"prefix":"10.1186","volume":"26","author":[{"given":"Qingmiao","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"issue":"12","key":"4444_CR1","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1073\/pnas.3.12.673","volume":"3","author":"CW Metz","year":"1917","unstructured":"Metz CW, Bridges CB. Incompatibility of Mutant Races in Drosophila. Proc Natl Acad Sci U S A. 1917;3(12):673\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3 Pt 2","key":"4444_CR2","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/0092-8674(85)90229-6","volume":"43","author":"KA Wharton","year":"1985","unstructured":"Wharton KA, Johansen KM, Xu T, Artavanis-Tsakonas S. Nucleotide sequence from the neurogenic locus notch implies a gene product that shares homology with proteins containing EGF-like repeats. Cell. 1985;43(3 Pt 2):567\u201381.","journal-title":"Cell"},{"issue":"7","key":"4444_CR3","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41580-025-00835-2","volume":"26","author":"SJ Bray","year":"2025","unstructured":"Bray SJ, Bigas A. Modes of Notch signalling in development and disease. Nat Rev Mol Cell Biol. 2025;26(7):522\u201337.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5415","key":"4444_CR4","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1126\/science.284.5415.770","volume":"284","author":"S Artavanis-Tsakonas","year":"1999","unstructured":"Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science. 1999;284(5415):770\u20136.","journal-title":"Science"},{"issue":"7","key":"4444_CR5","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/cac2.70017","volume":"45","author":"M Li","year":"2025","unstructured":"Li M, Cao S, Xu RH. Global trends and epidemiological shifts in gastrointestinal cancers: insights from the past four decades. Cancer Commun (Lond). 2025;45(7):774\u201388.","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"4444_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","volume":"159","author":"M Arnold","year":"2020","unstructured":"Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, et al. Global Burden of 5 Major Types of Gastrointestinal Cancer. Gastroenterology. 2020;159(1):335\u2013e349315.","journal-title":"Gastroenterology"},{"issue":"3","key":"4444_CR7","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"16","key":"4444_CR8","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1097\/CM9.0000000000003225","volume":"137","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Song K, Chen Y, Zhang Y, Dai M, Wu D, et al. Burden of six major types of digestive system cancers globally and in China. Chin Med J (Engl). 2024;137(16):1957\u201364.","journal-title":"Chin Med J (Engl)"},{"key":"4444_CR9","doi-asserted-by":"publisher","first-page":"216127","DOI":"10.1016\/j.canlet.2023.216127","volume":"560","author":"Y Chen","year":"2023","unstructured":"Chen Y, Chen T, Fang JY. Burden of gastrointestinal cancers in China from 1990 to 2019 and projection through 2029. Cancer Lett. 2023;560:216127.","journal-title":"Cancer Lett"},{"issue":"3","key":"4444_CR10","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1158\/2159-8290.CD-22-1038","volume":"13","author":"I Ben-Aharon","year":"2023","unstructured":"Ben-Aharon I, van Laarhoven HWM, Fontana E, Obermannova R, Nilsson M, Lordick F. Early-Onset Cancer in the Gastrointestinal Tract Is on the Rise-Evidence and Implications. Cancer Discov. 2023;13(3):538\u201351.","journal-title":"Cancer Discov"},{"issue":"2","key":"4444_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cpan.2025.01.003","volume":"21","author":"F Fang","year":"2025","unstructured":"Fang F, Tai R, Yang F, Dong R, Zhang Y. Bioinformatic methods uncover 5 diagnostic biomarkers associated with drug resistance and metastasis for gastrointestinal stromal tumor. Curr Pharm Anal. 2025;21(2):67\u201376.","journal-title":"Curr Pharm Anal"},{"issue":"1","key":"4444_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41392-024-02097-4","volume":"10","author":"T Zhan","year":"2025","unstructured":"Zhan T, Betge J, Schulte N, Dreikhausen L, Hirth M, Li M, et al. Digestive cancers: mechanisms, therapeutics and management. Signal Transduct Target Ther. 2025;10(1):24.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"4444_CR13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-024-01828-x","volume":"9","author":"Q Shi","year":"2024","unstructured":"Shi Q, Xue C, Zeng Y, Yuan X, Chu Q, Jiang S, et al. Notch signaling pathway in cancer: from mechanistic insights to targeted therapies. Signal Transduct Target Ther. 2024;9(1):128.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"4444_CR14","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1152\/physrev.00005.2017","volume":"97","author":"C Siebel","year":"2017","unstructured":"Siebel C, Lendahl U. Notch Signaling in Development, Tissue Homeostasis, and Disease. Physiol Rev. 2017;97(4):1235\u201394.","journal-title":"Physiol Rev"},{"issue":"2","key":"4444_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41573-020-00091-3","volume":"20","author":"S Majumder","year":"2021","unstructured":"Majumder S, Crabtree JS, Golde TE, Minter LM, Osborne BA, Miele L. Targeting Notch in oncology: the path forward. Nat Rev Drug Discov. 2021;20(2):125\u201344.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"4444_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(00)80336-0","volume":"90","author":"CM Blaumueller","year":"1997","unstructured":"Blaumueller CM, Qi H, Zagouras P, Artavanis-Tsakonas S. Intracellular cleavage of Notch leads to a heterodimeric receptor on the plasma membrane. Cell. 1997;90(2):281\u201391.","journal-title":"Cell"},{"issue":"Pt 19","key":"4444_CR17","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1242\/jcs.035683","volume":"121","author":"WR Gordon","year":"2008","unstructured":"Gordon WR, Arnett KL, Blacklow SC. The molecular logic of Notch signaling\u2013a structural and biochemical perspective. J Cell Sci. 2008;121(Pt 19):3109\u201319.","journal-title":"J Cell Sci"},{"key":"4444_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.dnarep.2018.04.002","volume":"66\u201367","author":"M Majidinia","year":"2018","unstructured":"Majidinia M, Darband SG, Kaviani M, Nabavi SM, Jahanban-Esfahlan R, Yousefi B. Cross-regulation between Notch signaling pathway and miRNA machinery in cancer. DNA Repair (Amst). 2018;66\u201367:30\u201341.","journal-title":"DNA Repair (Amst)"},{"issue":"6","key":"4444_CR19","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1515\/jtim-2024-0020","volume":"12","author":"Q Shi","year":"2024","unstructured":"Shi Q, Jiang S, Zeng Y, Yuan X, Zhang Y, Chu Q, et al. A Notch signaling pathway-related gene signature: Characterizing the immune microenvironment and predicting prognosis in hepatocellular carcinoma. J Transl Int Med. 2024;12(6):553\u201368.","journal-title":"J Transl Int Med"},{"key":"4444_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1476-4598-8-128","volume":"8","author":"S Mittal","year":"2009","unstructured":"Mittal S, Subramanyam D, Dey D, Kumar RV, Rangarajan A. Cooperation of Notch and Ras\/MAPK signaling pathways in human breast carcinogenesis. Mol Cancer. 2009;8:128.","journal-title":"Mol Cancer"},{"key":"4444_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-biophys-101920-082204","volume":"50","author":"D Sprinzak","year":"2021","unstructured":"Sprinzak D, Blacklow SC. Biophysics of Notch Signaling. Annu Rev Biophys. 2021;50:157\u201389.","journal-title":"Annu Rev Biophys"},{"issue":"7","key":"4444_CR22","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.celrep.2019.10.027","volume":"29","author":"A Pandey","year":"2019","unstructured":"Pandey A, Harvey BM, Lopez MF, Ito A, Haltiwanger RS, Jafar-Nejad H. Glycosylation of Specific Notch EGF Repeats by O-Fut1 and Fringe Regulates Notch Signaling in Drosophila. Cell Rep. 2019;29(7):2054\u201366. e2056.","journal-title":"Cell Rep"},{"issue":"5","key":"4444_CR23","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/jcp.24872","volume":"230","author":"H Wang","year":"2015","unstructured":"Wang H, Zang C, Liu XS, Aster JC. The role of Notch receptors in transcriptional regulation. J Cell Physiol. 2015;230(5):982\u20138.","journal-title":"J Cell Physiol"},{"issue":"12","key":"4444_CR24","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.tem.2021.08.002","volume":"32","author":"GE Moldovan","year":"2021","unstructured":"Moldovan GE, Miele L, Fazleabas AT. Notch signaling in reproduction. Trends Endocrinol Metab. 2021;32(12):1044\u201357.","journal-title":"Trends Endocrinol Metab"},{"key":"4444_CR25","doi-asserted-by":"publisher","first-page":"100938","DOI":"10.1016\/j.mam.2020.100938","volume":"79","author":"K Matsumoto","year":"2021","unstructured":"Matsumoto K, Luther KB, Haltiwanger RS. Diseases related to Notch glycosylation. Mol Aspects Med. 2021;79:100938.","journal-title":"Mol Aspects Med"},{"issue":"21","key":"4444_CR26","doi-asserted-by":"publisher","first-page":"5980","DOI":"10.1016\/j.cell.2025.07.009","volume":"188","author":"R Mout","year":"2025","unstructured":"Mout R, Jing R, Tanaka-Yano M, Egan ED, Eisenach H, Kononov MA, et al. Design of soluble Notch agonists that drive T cell development and boost immunity. Cell. 2025;188(21):5980\u2013e59945928.","journal-title":"Cell"},{"issue":"3","key":"4444_CR27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.devcel.2017.04.001","volume":"41","author":"RA Kovall","year":"2017","unstructured":"Kovall RA, Gebelein B, Sprinzak D, Kopan R. The Canonical Notch Signaling Pathway: Structural and Biochemical Insights into Shape, Sugar, and Force. Dev Cell. 2017;41(3):228\u201341.","journal-title":"Dev Cell"},{"key":"4444_CR28","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.3389\/fimmu.2018.01230","volume":"9","author":"MP Steinbuck","year":"2018","unstructured":"Steinbuck MP, Winandy S. A Review of Notch Processing With New Insights Into Ligand-Independent Notch Signaling in T-Cells. Front Immunol. 2018;9:1230.","journal-title":"Front Immunol"},{"issue":"2","key":"4444_CR29","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.cell.2009.03.045","volume":"137","author":"R Kopan","year":"2009","unstructured":"Kopan R, Ilagan MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137(2):216\u201333.","journal-title":"Cell"},{"issue":"1","key":"4444_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41392-022-00934-y","volume":"7","author":"B Zhou","year":"2022","unstructured":"Zhou B, Lin W, Long Y, Yang Y, Zhang H, Wu K, et al. Notch signaling pathway: architecture, disease, and therapeutics. Signal Transduct Target Ther. 2022;7(1):95.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"4444_CR31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.tcb.2012.02.003","volume":"22","author":"P Andersen","year":"2012","unstructured":"Andersen P, Uosaki H, Shenje LT, Kwon C. Non-canonical Notch signaling: emerging role and mechanism. Trends Cell Biol. 2012;22(5):257\u201365.","journal-title":"Trends Cell Biol"},{"issue":"7","key":"4444_CR32","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/s41417-021-00411-8","volume":"29","author":"H Gonz\u00e1lez-King","year":"2022","unstructured":"Gonz\u00e1lez-King H, Tejedor S, Ciria M, Gil-Barrachina M, Soriano-Navarro M, S\u00e1nchez-S\u00e1nchez R, et al. Non-classical Notch signaling by MDA-MB-231 breast cancer cell-derived small extracellular vesicles promotes malignancy in poorly invasive MCF-7 cells. Cancer Gene Ther. 2022;29(7):1056\u201369.","journal-title":"Cancer Gene Ther"},{"issue":"4","key":"4444_CR33","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.bjoms.2019.03.005","volume":"57","author":"E Anitua","year":"2019","unstructured":"Anitua E, Alkhraisat MH. Single-unit short dental implants. Would they survive a long period of service? Br J Oral Maxillofac Surg. 2019;57(4):387\u20138.","journal-title":"Br J Oral Maxillofac Surg"},{"key":"4444_CR34","doi-asserted-by":"crossref","unstructured":"Nakamura K, Takahashi K, Sakaguchi I, Satoh T, Zhang L, Yanai H et al. A Novel Glycoengineered Humanized Antibody Targeting DLK1 Exhibits Potent Anti-Tumor Activity in DLK1-Expressing Liver Cancer Cell Xenograft Models. Int J Mol Sci. 2024;25(24):13627.","DOI":"10.3390\/ijms252413627"},{"key":"4444_CR35","doi-asserted-by":"crossref","unstructured":"Perram\u00f3n M. and Jim\u00e9nez W. Pituitary Tumor-Transforming Gene 1\/Delta like Non-Canonical Notch Ligand 1 Signaling in Chronic Liver Diseases. Int J Mol Sci. 2022;23(13):6897.","DOI":"10.3390\/ijms23136897"},{"issue":"7","key":"4444_CR36","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1093\/neuonc\/noaf056","volume":"27","author":"Y Deng","year":"2025","unstructured":"Deng Y, Yuan Z, Jin X, Wang Z, Gong R, Ren S, et al. Synapsin III promotes neuronal-like transdifferentiation of glioblastoma stem cells by disrupting JAG1-Notch1 interaction. Neuro Oncol. 2025;27(7):1686\u2013701.","journal-title":"Neuro Oncol"},{"issue":"1","key":"4444_CR37","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1038\/s41467-024-48347-5","volume":"15","author":"H Huang","year":"2024","unstructured":"Huang H, Jiang Y, Liu J, Luo D, Yuan J, Mu R, et al. Jag1\/2 maintain esophageal homeostasis and suppress foregut tumorigenesis by restricting the basal progenitor cell pool. Nat Commun. 2024;15(1):4124.","journal-title":"Nat Commun"},{"issue":"6","key":"4444_CR38","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1136\/gutjnl-2015-310811","volume":"66","author":"GB Gifford","year":"2017","unstructured":"Gifford GB, Demitrack ES, Keeley TM, Tam A, La Cunza N, Dedhia PH, et al. Notch1 and Notch2 receptors regulate mouse and human gastric antral epithelial cell homoeostasis. Gut. 2017;66(6):1001\u201311.","journal-title":"Gut"},{"issue":"3","key":"4444_CR39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/jmp6030024","volume":"6","author":"S Vernygorodskyi","year":"2025","unstructured":"Vernygorodskyi S, Tonchev AB, Bratoeva Kameliya Z. Gastric Epithelial Cell Plasticity and Molecular Mechanisms of Metaplastic Transformations in the Stomach. J Mol Pathol. 2025;6(3):24.","journal-title":"J Mol Pathol"},{"issue":"1","key":"4444_CR40","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/nyas.15137","volume":"1535","author":"AN Naser","year":"2024","unstructured":"Naser AN, Xing T, Tatum R, Lu Q, Boyer PJ, Chen YH. Colonic crypt stem cell functions are controlled by tight junction protein claudin-7 through Notch\/Hippo signaling. Ann N Y Acad Sci. 2024;1535(1):92\u2013108.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"4444_CR41","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41392-021-00535-1","volume":"6","author":"Y Pu","year":"2021","unstructured":"Pu Y, Song Y, Zhang M, Long C, Li J, Wang Y, et al. GOLM1 restricts colitis and colon tumorigenesis by ensuring Notch signaling equilibrium in intestinal homeostasis. Signal Transduct Target Ther. 2021;6(1):148.","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"4444_CR42","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.7150\/ijbs.93739","volume":"20","author":"C Xu","year":"2024","unstructured":"Xu C, Fang X, Song Y, Xiang Z, Xu X, Wei X. Transcriptional Control: A Directional Sign at the Crossroads of Adult Hepatic Progenitor Cells\u2019 Fates. Int J Biol Sci. 2024;20(9):3544\u201356.","journal-title":"Int J Biol Sci"},{"issue":"11","key":"4444_CR43","doi-asserted-by":"publisher","first-page":"6103","DOI":"10.1073\/pnas.1912146117","volume":"117","author":"M Liu","year":"2020","unstructured":"Liu M, Yan Q, Sun Y, Nam Y, Hu L, Loong JH, et al. A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets. Proc Natl Acad Sci U S A. 2020;117(11):6103\u201313.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"4444_CR44","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jcmgh.2023.07.013","volume":"16","author":"L Pan","year":"2023","unstructured":"Pan L, Mulaw MA, Gout J, Guo M, Zarrin H, Schwarz P, et al. RBPJ Deficiency Sensitizes Pancreatic Acinar Cells to KRAS-Mediated Pancreatic Intraepithelial Neoplasia Initiation. Cell Mol Gastroenterol Hepatol. 2023;16(5):783\u2013807.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"4","key":"4444_CR45","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/path.6356","volume":"264","author":"G Huang","year":"2024","unstructured":"Huang G, Ternes L, Lanciault C, MacPherson-Hawthorne K, Chang YH, Sears RC, et al. Suppression of dystroglycan function accompanies pancreatic acinar-to-ductal metaplasia and favours dysplasia development. J Pathol. 2024;264(4):411\u201322.","journal-title":"J Pathol"},{"issue":"5","key":"4444_CR46","doi-asserted-by":"publisher","first-page":"915","DOI":"10.2337\/db19-0795","volume":"69","author":"M Rubey","year":"2020","unstructured":"Rubey M, Chhabra NF, Gradinger D, Sanz-Moreno A, Lickert H, Przemeck GKH, et al. DLL1- and DLL4-Mediated Notch Signaling Is Essential for Adult Pancreatic Islet Homeostasis. Diabetes. 2020;69(5):915\u201326.","journal-title":"Diabetes"},{"key":"4444_CR47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.oraloncology.2017.05.004","volume":"70","author":"J Ali","year":"2017","unstructured":"Ali J, Sabiha B, Jan HU, Haider SA, Khan AA, Ali SS. Genetic etiology of oral cancer. Oral Oncol. 2017;70:23\u20138.","journal-title":"Oral Oncol"},{"issue":"12","key":"4444_CR48","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.2174\/1871530321666210421125231","volume":"21","author":"A Pandey","year":"2021","unstructured":"Pandey A, Bhuvanadas S, Joseph JP, Jayaraj R, Devi A. Notch Signalling: A Potential Therapeutic Pathway in Oral Squamous Cell Carcinoma. Endocr Metab Immune Disord Drug Targets. 2021;21(12):2159\u201368.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"2","key":"4444_CR49","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2174\/0113892029284920240212091903","volume":"25","author":"B Neha","year":"2024","unstructured":"Neha B, Rafat A, Tehseen F, Zeba A, Nousheen F. Expression Profiling of EMT Transcriptional Regulators ZEB1 and ZEB2 in Different Histopathological Grades of Oral Squamous Cell Carcinoma Patients. Curr Genom. 2024;25(2):140\u201351.","journal-title":"Curr Genom"},{"key":"4444_CR50","doi-asserted-by":"publisher","first-page":"153474","DOI":"10.1016\/j.prp.2021.153474","volume":"223","author":"YH Wu-Chou","year":"2021","unstructured":"Wu-Chou YH, Hsieh CH, Liao CT, Lin YT, Fan WL, Yang CH. NOTCH1 mutations as prognostic marker in oral squamous cell carcinoma. Pathol Res Pract. 2021;223:153474.","journal-title":"Pathol Res Pract"},{"issue":"8","key":"4444_CR51","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/jop.13460","volume":"52","author":"H Ahmed","year":"2023","unstructured":"Ahmed H, Paterson I, Aziz SA, Cremona O, Robinson M, Carrozzo M, et al. Expression of Epsin3 and its interaction with Notch signalling in oral epithelial dysplasia and oral squamous cell carcinoma. J Oral Pathol Med. 2023;52(8):710\u20137.","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"4444_CR52","doi-asserted-by":"publisher","first-page":"2287122","DOI":"10.1080\/15384047.2023.2287122","volume":"25","author":"Y Chen","year":"2024","unstructured":"Chen Y, Chen Y, Liu W. Chaperonin containing TCP1 subunit 6A may activate Notch and Wnt pathways to facilitate the malignant behaviors and cancer stemness in oral squamous cell carcinoma. Cancer Biol Ther. 2024;25(1):2287122.","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"4444_CR53","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1080\/15384047.2018.1529119","volume":"20","author":"Z Liu","year":"2019","unstructured":"Liu Z, Li H, Fan S, Lin H, Lian W. STAT3-induced upregulation of long noncoding RNA HNF1A-AS1 promotes the progression of oral squamous cell carcinoma via activating Notch signaling pathway. Cancer Biol Ther. 2019;20(4):444\u201353.","journal-title":"Cancer Biol Ther"},{"key":"4444_CR54","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.lfs.2016.05.019","volume":"156","author":"H Mk","year":"2016","unstructured":"Mk H, Prince S, Mohan AM, Krishnan KV, Devi A. Association of Notch4 with metastasis in human oral squamous cell carcinoma. Life Sci. 2016;156:38\u201346.","journal-title":"Life Sci"},{"issue":"1","key":"4444_CR55","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41420-022-00899-5","volume":"8","author":"LJ Li","year":"2022","unstructured":"Li LJ, Chang PM, Li CH, Chang YC, Lai TC, Su CY, et al. FAS receptor regulates NOTCH activity through ERK-JAG1 axis activation and controls oral cancer stemness ability and pulmonary metastasis. Cell Death Discov. 2022;8(1):101.","journal-title":"Cell Death Discov"},{"issue":"5","key":"4444_CR56","doi-asserted-by":"publisher","first-page":"5940","DOI":"10.1002\/jcp.27022","volume":"234","author":"Y Zheng","year":"2019","unstructured":"Zheng Y, Wang Z, Xiong X, Zhong Y, Zhang W, Dong Y, et al. Membrane-tethered Notch1 exhibits oncogenic property via activation of EGFR-PI3K-AKT pathway in oral squamous cell carcinoma. J Cell Physiol. 2019;234(5):5940\u201352.","journal-title":"J Cell Physiol"},{"issue":"4","key":"4444_CR57","doi-asserted-by":"publisher","first-page":"e0154112","DOI":"10.1371\/journal.pone.0154112","volume":"11","author":"K Kayamori","year":"2016","unstructured":"Kayamori K, Katsube K, Sakamoto K, Ohyama Y, Hirai H, Yukimori A, et al. NOTCH3 Is Induced in Cancer-Associated Fibroblasts and Promotes Angiogenesis in Oral Squamous Cell Carcinoma. PLoS ONE. 2016;11(4):e0154112.","journal-title":"PLoS ONE"},{"issue":"1","key":"4444_CR58","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s13046-024-03191-9","volume":"43","author":"Z Li","year":"2024","unstructured":"Li Z, Sun M, Yang R, Wang Z, Zhu Q, Zhang Y, et al. Mediator complex subunit 1 promotes oral squamous cell carcinoma progression by activating MMP9 transcription and suppressing CD8(+) T cell antitumor immunity. J Exp Clin Cancer Res. 2024;43(1):270.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"4444_CR59","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1053\/j.gastro.2022.05.054","volume":"163","author":"E Morgan","year":"2022","unstructured":"Morgan E, Soerjomataram I, Rumgay H, Coleman HG, Thrift AP, Vignat J, et al. The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020. Gastroenterology. 2022;163(3):649\u2013e658642.","journal-title":"Gastroenterology"},{"key":"4444_CR60","first-page":"1","volume":"17","author":"M Zhifeng","year":"2024","unstructured":"Zhifeng M, Ting Z, Haiyong W, Bin W, Linhai F, Guangmao Y. E2F1 Reduces Sorafenib\u2019s Sensitivity of Esophageal Carcinoma Cells via Modulating the miR-29c-3p\/COL11A1 Signaling Axis. Curr Mol Pharmacol. 2024;17:1\u201325.","journal-title":"Curr Mol Pharmacol"},{"key":"4444_CR61","doi-asserted-by":"publisher","first-page":"1495200","DOI":"10.3389\/fonc.2024.1495200","volume":"14","author":"X Zhang","year":"2024","unstructured":"Zhang X, Lian J, Chen F, Wang K, Xue H, Jia S, et al. Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma. Front Oncol. 2024;14:1495200.","journal-title":"Front Oncol"},{"issue":"3","key":"4444_CR62","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1053\/j.gastro.2023.05.030","volume":"165","author":"KP Ko","year":"2023","unstructured":"Ko KP, Huang Y, Zhang S, Zou G, Kim B, Zhang J, et al. Key Genetic Determinants Driving Esophageal Squamous Cell Carcinoma Initiation and Immune Evasion. Gastroenterology. 2023;165(3):613\u2013e628620.","journal-title":"Gastroenterology"},{"key":"4444_CR63","doi-asserted-by":"publisher","first-page":"115639","DOI":"10.1016\/j.bcp.2023.115639","volume":"214","author":"K Knapp","year":"2023","unstructured":"Knapp K, Verchio V, Coburn-Flynn O, Li Y, Xiong Z, Morrison JC, et al. Exploring cell competition for the prevention and therapy of esophageal squamous cell carcinoma. Biochem Pharmacol. 2023;214:115639.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"4444_CR64","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41392-025-02309-5","volume":"10","author":"C Li","year":"2025","unstructured":"Li C, Wu P, Xie X, Chen X, Chen L, Zhu L, et al. Aberrant Notch-signaling promotes tumor angiogenesis in esophageal squamous-cell carcinoma. Signal Transduct Target Ther. 2025;10(1):233.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"4444_CR65","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00018-024-05534-3","volume":"81","author":"X Feng","year":"2024","unstructured":"Feng X, Chen J, Lian J, Dong T, Gao Y, Zhang X, et al. The glycogene alterations and potential effects in esophageal squamous cell carcinoma. Cell Mol Life Sci. 2024;81(1):481.","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"4444_CR66","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.ccell.2025.02.009","volume":"43","author":"J Chang","year":"2025","unstructured":"Chang J, Lu J, Liu Q, Xiang T, Zhang S, Yi Y, et al. Single-cell multi-stage spatial evolutional map of esophageal carcinogenesis. Cancer Cell. 2025;43(3):380\u2013e397387.","journal-title":"Cancer Cell"},{"issue":"2","key":"4444_CR67","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s11010-020-03956-8","volume":"476","author":"MM Forghanifard","year":"2021","unstructured":"Forghanifard MM, Kasebi P, Abbaszadegan MR. SOX2\/SALL4 stemness axis modulates Notch signaling genes to maintain self-renewal capacity of esophageal squamous cell carcinoma. Mol Cell Biochem. 2021;476(2):921\u20139.","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"4444_CR68","doi-asserted-by":"publisher","first-page":"705","DOI":"10.20892\/j.issn.2095-3941.2020.0290","volume":"18","author":"D Yue","year":"2021","unstructured":"Yue D, Liu S, Zhang T, Wang Y, Qin G, Chen X, et al. NEDD9 promotes cancer stemness by recruiting myeloid-derived suppressor cells via CXCL8 in esophageal squamous cell carcinoma. Cancer Biol Med. 2021;18(3):705\u201320.","journal-title":"Cancer Biol Med"},{"issue":"3","key":"4444_CR69","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/cac2.12645","volume":"45","author":"W Jiang","year":"2025","unstructured":"Jiang W, Zhang B, Xu J, Xue L, Wang L. Current status and perspectives of esophageal cancer: a comprehensive review. Cancer Commun (Lond). 2025;45(3):281\u2013331.","journal-title":"Cancer Commun (Lond)"},{"issue":"3","key":"4444_CR70","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1136\/gutjnl-2022-327076","volume":"72","author":"L Chen","year":"2023","unstructured":"Chen L, Lu H, Peng D, Cao LL, Ballout F, Srirmajayam K, et al. Activation of NOTCH signaling via DLL1 is mediated by APE1-redox-dependent NF-\u03baB activation in oesophageal adenocarcinoma. Gut. 2023;72(3):421\u201332.","journal-title":"Gut"},{"issue":"2","key":"4444_CR71","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1053\/j.gastro.2020.04.033","volume":"159","author":"B Kunze","year":"2020","unstructured":"Kunze B, Wein F, Fang HY, Anand A, Baumeister T, Strangmann J, et al. Notch Signaling Mediates Differentiation in Barrett\u2019s Esophagus and Promotes Progression to Adenocarcinoma. Gastroenterology. 2020;159(2):575\u201390.","journal-title":"Gastroenterology"},{"issue":"1","key":"4444_CR72","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s43556-025-00285-4","volume":"6","author":"J Zhou","year":"2025","unstructured":"Zhou J, Zhao R, Li Z, Ma X, Jin W, Yuan Y, et al. LncRNA small nucleolar RNA host gene 1 (SNHG1) mediates acidic bile salt-induced EMT via the ULK1-Notch1 axis in Barrett\u2019s esophagus. Mol Biomed. 2025;6(1):49.","journal-title":"Mol Biomed"},{"issue":"1","key":"4444_CR73","first-page":"67","volume":"44","author":"Z Ren","year":"2019","unstructured":"Ren Z, Zhang C, Ma L, Zhang X, Shi S, Tang D, et al. Lysophosphatidic acid induces the migration and invasion of SGC-7901 gastric cancer cells through the LPA2 and Notch signaling pathways. Int J Mol Med. 2019;44(1):67\u201378.","journal-title":"Int J Mol Med"},{"key":"4444_CR74","doi-asserted-by":"publisher","first-page":"217886","DOI":"10.1016\/j.canlet.2025.217886","volume":"629","author":"J Peng","year":"2025","unstructured":"Peng J, Yin Y, Liu X, Deng C, Wang P, Hu X, et al. CD51 promotes gastric cancer stemness via blocking Numb-mediated Notch1 degradation. Cancer Lett. 2025;629:217886.","journal-title":"Cancer Lett"},{"issue":"11","key":"4444_CR75","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/s41419-021-04228-z","volume":"12","author":"X Mao","year":"2021","unstructured":"Mao X, Ji T, Liu A, Weng Y. ELK4-mediated lncRNA SNHG22 promotes gastric cancer progression through interacting with EZH2 and regulating miR-200c-3p\/Notch1 axis. Cell Death Dis. 2021;12(11):957.","journal-title":"Cell Death Dis"},{"issue":"11","key":"4444_CR76","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1038\/s41418-018-0236-y","volume":"26","author":"TP Xu","year":"2019","unstructured":"Xu TP, Ma P, Wang WY, Shuai Y, Wang YF, Yu T, et al. KLF5 and MYC modulated LINC00346 contributes to gastric cancer progression through acting as a competing endogeous RNA and indicates poor outcome. Cell Death Differ. 2019;26(11):2179\u201393.","journal-title":"Cell Death Differ"},{"issue":"9","key":"4444_CR77","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1038\/s41388-020-01579-3","volume":"40","author":"W Kang","year":"2021","unstructured":"Kang W, Zhang J, Huang T, Zhou Y, Wong CC, Chan RCK, et al. NOTCH3, a crucial target of miR-491-5p\/miR-875-5p, promotes gastric carcinogenesis by upregulating PHLDB2 expression and activating Akt pathway. Oncogene. 2021;40(9):1578\u201394.","journal-title":"Oncogene"},{"key":"4444_CR78","doi-asserted-by":"publisher","first-page":"216841","DOI":"10.1016\/j.canlet.2024.216841","volume":"593","author":"L Wang","year":"2024","unstructured":"Wang L, Mao X, Yu X, Su J, Li Z, Chen Z, et al. FPR3 reprograms glycolytic metabolism and stemness in gastric cancer via calcium-NFATc1 pathway. Cancer Lett. 2024;593:216841.","journal-title":"Cancer Lett"},{"key":"4444_CR79","doi-asserted-by":"publisher","first-page":"215837","DOI":"10.1016\/j.canlet.2022.215837","volume":"549","author":"D He","year":"2022","unstructured":"He D, Chen M, Chang L, Gu J, Liu F, Gao X, et al. De novo pyrimidine synthesis fuels glycolysis and confers chemoresistance in gastric cancer. Cancer Lett. 2022;549:215837.","journal-title":"Cancer Lett"},{"issue":"2\u20133","key":"4444_CR80","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10863-025-10057-y","volume":"57","author":"X She","year":"2025","unstructured":"She X, Geng L, Zhao Q, Guo H, Rong G, Luo Y, et al. Targeting hypoxia-induced HIF-1\u03b1\/JMJD3\/Notch axis in gastric cancer therapy. J Bioenerg Biomembr. 2025;57(2\u20133):107\u201317.","journal-title":"J Bioenerg Biomembr"},{"key":"4444_CR81","doi-asserted-by":"publisher","first-page":"574937","DOI":"10.3389\/fonc.2020.574937","volume":"10","author":"Y Cui","year":"2020","unstructured":"Cui Y, Li Q, Li W, Wang Y, Lv F, Shi X, et al. NOTCH3 is a Prognostic Factor and Is Correlated With Immune Tolerance in Gastric Cancer. Front Oncol. 2020;10:574937.","journal-title":"Front Oncol"},{"issue":"10","key":"4444_CR82","doi-asserted-by":"publisher","first-page":"5411","DOI":"10.1007\/s11010-025-05322-y","volume":"480","author":"S Du","year":"2025","unstructured":"Du S, Li P, Liu Y, Cai B, Li G, Wang W, et al. FOXM1 upregulation, promotes immune escape in gastric cancer through activation of Notch signaling pathway. Mol Cell Biochem. 2025;480(10):5411\u201327.","journal-title":"Mol Cell Biochem"},{"issue":"8","key":"4444_CR83","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1016\/j.cmet.2024.05.013","volume":"36","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Wang Y, Chen G, Sun F, Wu Q, Huang Q, et al. Nicotinamide metabolism face-off between macrophages and fibroblasts manipulates the microenvironment in gastric cancer. Cell Metab. 2024;36(8):1806\u2013e18221811.","journal-title":"Cell Metab"},{"issue":"5","key":"4444_CR84","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1053\/j.gastro.2023.01.033","volume":"164","author":"MR Toh","year":"2023","unstructured":"Toh MR, Wong EYT, Wong SH, Ng AWT, Loo LH, Chow PK, et al. Global Epidemiology and Genetics of Hepatocellular Carcinoma. Gastroenterology. 2023;164(5):766\u201382.","journal-title":"Gastroenterology"},{"issue":"7","key":"4444_CR85","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2174\/0115734129322567240821052326","volume":"20","author":"VC Chandni","year":"2024","unstructured":"Chandni VC, Namira TM, Diksha VS, Utkarsh BK. Vibrational Spectrophotometry: A Comprehensive Review on the Diagnosis of Gastric and Liver Cancer. Curr Pharm Anal. 2024;20(7):453\u201365.","journal-title":"Curr Pharm Anal"},{"issue":"1","key":"4444_CR86","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12935-021-01924-w","volume":"21","author":"Z Farzaneh","year":"2021","unstructured":"Farzaneh Z, Vosough M, Agarwal T, Farzaneh M. Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approaches. Cancer Cell Int. 2021;21(1):208.","journal-title":"Cancer Cell Int"},{"issue":"10","key":"4444_CR87","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41419-024-07089-4","volume":"15","author":"ZX Chen","year":"2024","unstructured":"Chen ZX, Mu MY, Yang G, Qi H, Fu XB, Wang GS, et al. Hypoxia-induced DTL promotes the proliferation, metastasis, and sorafenib resistance of hepatocellular carcinoma through ubiquitin-mediated degradation of SLTM and subsequent Notch pathway activation. Cell Death Dis. 2024;15(10):734.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4444_CR88","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12967-023-04085-8","volume":"21","author":"S Bai","year":"2023","unstructured":"Bai S, Zhao Y, Chen W, Peng W, Wang Y, Xiong S, et al. The stromal-tumor amplifying STC1-Notch1 feedforward signal promotes the stemness of hepatocellular carcinoma. J Transl Med. 2023;21(1):236.","journal-title":"J Transl Med"},{"issue":"1","key":"4444_CR89","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12964-025-02369-8","volume":"23","author":"H Huang","year":"2025","unstructured":"Huang H, Peng W, Zhou Q, Zhao Y, Liu L, Cui H, et al. Senescent fibroblasts secrete CTHRC1 to promote cancer stemness in hepatocellular carcinoma. Cell Commun Signal. 2025;23(1):379.","journal-title":"Cell Commun Signal"},{"issue":"7","key":"4444_CR90","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1053\/j.gastro.2023.02.005","volume":"164","author":"C Zhou","year":"2023","unstructured":"Zhou C, Weng J, Liu C, Liu S, Hu Z, Xie X, et al. Disruption of SLFN11 Deficiency-Induced CCL2 Signaling and Macrophage M2 Polarization Potentiates Anti-PD-1 Therapy Efficacy in Hepatocellular Carcinoma. Gastroenterology. 2023;164(7):1261\u201378.","journal-title":"Gastroenterology"},{"issue":"6","key":"4444_CR91","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jhep.2024.12.016","volume":"82","author":"S Cappuyns","year":"2025","unstructured":"Cappuyns S, Piqu\u00e9-Gili M, Esteban-Fabr\u00f3 R, Philips G, Balaseviciute U, Pinyol R, et al. Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab\u2009+\u2009bevacizumab in advanced hepatocellular carcinoma. J Hepatol. 2025;82(6):1036\u201349.","journal-title":"J Hepatol"},{"issue":"16","key":"4444_CR92","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1158\/0008-5472.CAN-18-1691","volume":"79","author":"YC Ye","year":"2019","unstructured":"Ye YC, Zhao JL, Lu YT, Gao CC, Yang Y, Liang SQ, et al. NOTCH Signaling via WNT Regulates the Proliferation of Alternative, CCR2-Independent Tumor-Associated Macrophages in Hepatocellular Carcinoma. Cancer Res. 2019;79(16):4160\u201372.","journal-title":"Cancer Res"},{"issue":"1","key":"4444_CR93","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13046-019-1135-x","volume":"38","author":"M Jin","year":"2019","unstructured":"Jin M, Wang J, Ji X, Cao H, Zhu J, Chen Y, et al. MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS\/Nrf2\/Notch pathway in hepatocellular carcinoma. J Exp Clin Cancer Res. 2019;38(1):136.","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"4444_CR94","doi-asserted-by":"publisher","first-page":"102208","DOI":"10.1016\/j.xcrm.2025.102208","volume":"6","author":"M Xu","year":"2025","unstructured":"Xu M, Zheng Y, Chen J, Gao C, Zhu M, Ma A, et al. CLDN4 palmitoylation promotes hepatic-to-biliary lineage transition and lenvatinib resistance in hepatocellular carcinoma. Cell Rep Med. 2025;6(7):102208.","journal-title":"Cell Rep Med"},{"issue":"1","key":"4444_CR95","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s13046-019-1382-x","volume":"38","author":"L Zhang","year":"2019","unstructured":"Zhang L, Chen J, Yong J, Qiao L, Xu L, Liu C. An essential role of RNF187 in Notch1 mediated metastasis of hepatocellular carcinoma. J Exp Clin Cancer Res. 2019;38(1):384.","journal-title":"J Exp Clin Cancer Res"},{"issue":"11","key":"4444_CR96","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41419-024-07214-3","volume":"15","author":"Y Lun","year":"2024","unstructured":"Lun Y, Sun J, Wei L, Liu B, Li Z, Dong W, et al. SPINK13 acts as a tumor suppressor in hepatocellular carcinoma by inhibiting Akt phosphorylation. Cell Death Dis. 2024;15(11):822.","journal-title":"Cell Death Dis"},{"issue":"8","key":"4444_CR97","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41419-024-07016-7","volume":"15","author":"HR Ahn","year":"2024","unstructured":"Ahn HR, Kim S, Baek GO, Yoon MG, Kang M, Ng JT, et al. Effect of Sortilin1 on promoting angiogenesis and systemic metastasis in hepatocellular carcinoma via the Notch signaling pathway and CD133. Cell Death Dis. 2024;15(8):634.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4444_CR98","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13046-021-02216-x","volume":"41","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Lin J, Yan Y, Meng S, Liao H, Chen R, et al. INPP5F translocates into cytoplasm and interacts with ASPH to promote tumor growth in hepatocellular carcinoma. J Exp Clin Cancer Res. 2022;41(1):13.","journal-title":"J Exp Clin Cancer Res"},{"key":"4444_CR99","doi-asserted-by":"publisher","first-page":"1581398","DOI":"10.3389\/fimmu.2025.1581398","volume":"16","author":"X Peng","year":"2025","unstructured":"Peng X, Liu Z, Luo C, Sun R, Zhang Y, Li B, et al. PSMD12 promotes hepatocellular carcinoma progression by stabilizing CDK1. Front Immunol. 2025;16:1581398.","journal-title":"Front Immunol"},{"issue":"3","key":"4444_CR100","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3350\/cmh.2024.0895","volume":"31","author":"GW Ji","year":"2025","unstructured":"Ji GW, Xu ZG, Liu SC, Cao SY, Jiao CY, Lu M, et al. Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target. Clin Mol Hepatol. 2025;31(3):935\u201359.","journal-title":"Clin Mol Hepatol"},{"issue":"3","key":"4444_CR101","doi-asserted-by":"publisher","first-page":"pbaf021","DOI":"10.1093\/pcmedi\/pbaf021","volume":"8","author":"X Lu","year":"2025","unstructured":"Lu X, Xu S, Deng Z, Wang MJ, Chen F. Molecular mechanisms and genetic features of cholangiocarcinoma: implications for targeted therapeutic strategies. Precis Clin Med. 2025;8(3):pbaf021.","journal-title":"Precis Clin Med"},{"issue":"1","key":"4444_CR102","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s13046-022-02536-6","volume":"41","author":"S Mancarella","year":"2022","unstructured":"Mancarella S, Gigante I, Serino G, Pizzuto E, Dituri F, Valentini MF, et al. Crenigacestat blocking notch pathway reduces liver fibrosis in the surrounding ecosystem of intrahepatic CCA viaTGF-\u03b2 inhibition. J Exp Clin Cancer Res. 2022;41(1):331.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"4444_CR103","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13046-022-02283-8","volume":"41","author":"S Mancarella","year":"2022","unstructured":"Mancarella S, Serino G, Gigante I, Cigliano A, Ribback S, Sanese P, et al. CD90 is regulated by notch1 and hallmarks a more aggressive intrahepatic cholangiocarcinoma phenotype. J Exp Clin Cancer Res. 2022;41(1):65.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"4444_CR104","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1186\/s13046-019-1477-4","volume":"38","author":"JH Li","year":"2019","unstructured":"Li JH, Zhu XX, Li FX, Huang CS, Huang XT, Wang JQ, et al. MFAP5 facilitates the aggressiveness of intrahepatic Cholangiocarcinoma by activating the Notch1 signaling pathway. J Exp Clin Cancer Res. 2019;38(1):476.","journal-title":"J Exp Clin Cancer Res"},{"issue":"23","key":"4444_CR105","doi-asserted-by":"publisher","first-page":"5305","DOI":"10.1158\/0008-5472.CAN-20-1161","volume":"80","author":"T Matsumori","year":"2020","unstructured":"Matsumori T, Kodama Y, Takai A, Shiokawa M, Nishikawa Y, Matsumoto T, et al. Hes1 Is Essential in Proliferating Ductal Cell-Mediated Development of Intrahepatic Cholangiocarcinoma. Cancer Res. 2020;80(23):5305\u201316.","journal-title":"Cancer Res"},{"issue":"1","key":"4444_CR106","doi-asserted-by":"publisher","first-page":"101417","DOI":"10.1016\/j.jcmgh.2024.101417","volume":"19","author":"W Ma","year":"2025","unstructured":"Ma W, Zhang J, Chen W, Liu N, Wu T. Notch-Driven Cholangiocarcinogenesis Involves the Hippo Pathway Effector TAZ via METTL3-m6A-YTHDF1. Cell Mol Gastroenterol Hepatol. 2025;19(1):101417.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"2","key":"4444_CR107","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1053\/j.gastro.2022.05.007","volume":"163","author":"S Hu","year":"2022","unstructured":"Hu S, Molina L, Tao J, Liu S, Hassan M, Singh S, et al. NOTCH-YAP1\/TEAD-DNMT1 Axis Drives Hepatocyte Reprogramming Into Intrahepatic Cholangiocarcinoma. Gastroenterology. 2022;163(2):449\u201365.","journal-title":"Gastroenterology"},{"issue":"14","key":"4444_CR108","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.7150\/ijms.95964","volume":"21","author":"T Shang","year":"2024","unstructured":"Shang T, Chen X, Xue H, Wu Y, Lin S, Zhu Y. The PKHD1 gene inhibits tumor proliferation and invasion in intrahepatic cholangiocarcinoma by activating the Notch pathway. Int J Med Sci. 2024;21(14):2655\u201363.","journal-title":"Int J Med Sci"},{"key":"4444_CR109","doi-asserted-by":"crossref","unstructured":"Kerdkumthong K, Roytrakul S, Songsurin K, Pratummanee K, Runsaeng P, Obchoei S. Proteomics and Bioinformatics Identify Drug-Resistant-Related Genes with Prognostic Potential in Cholangiocarcinoma. Biomolecules. 2024;14(8):969.","DOI":"10.3390\/biom14080969"},{"issue":"8","key":"4444_CR110","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/s41418-025-01460-4","volume":"32","author":"Q Mei","year":"2025","unstructured":"Mei Q, Zhang Y, Li H, Ma W, Huang W, Wu Z, et al. Hepatic factor MANF drives hepatocytes reprogramming by detaining cytosolic CK19 in intrahepatic cholangiocarcinoma. Cell Death Differ. 2025;32(8):1441\u201359.","journal-title":"Cell Death Differ"},{"issue":"24","key":"4444_CR111","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1038\/s41388-018-0188-1","volume":"37","author":"J Wang","year":"2018","unstructured":"Wang J, Dong M, Xu Z, Song X, Zhang S, Qiao Y, et al. Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice. Oncogene. 2018;37(24):3229\u201342.","journal-title":"Oncogene"},{"issue":"43","key":"4444_CR112","doi-asserted-by":"publisher","first-page":"12250","DOI":"10.1073\/pnas.1600067113","volume":"113","author":"RV Guest","year":"2016","unstructured":"Guest RV, Boulter L, Dwyer BJ, Kendall TJ, Man TY, Minnis-Lyons SE, et al. Notch3 drives development and progression of cholangiocarcinoma. Proc Natl Acad Sci U S A. 2016;113(43):12250\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4444_CR113","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12943-024-01979-z","volume":"23","author":"Z He","year":"2024","unstructured":"He Z, Zhong Y, Regmi P, Lv T, Ma W, Wang J, et al. Exosomal long non-coding RNA TRPM2-AS promotes angiogenesis in gallbladder cancer through interacting with PABPC1 to activate NOTCH1 signaling pathway. Mol Cancer. 2024;23(1):65.","journal-title":"Mol Cancer"},{"issue":"7","key":"4444_CR114","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.21873\/anticanres.16462","volume":"43","author":"L Na","year":"2023","unstructured":"Na L, Onishi H, Morisaki S, Ichimiya S, Yamada Y, Masuda S, et al. MAML3 Contributes to Induction of Malignant Phenotype of Gallbladder Cancer Through Morphogenesis Signalling Under Hypoxia. Anticancer Res. 2023;43(7):2909\u201322.","journal-title":"Anticancer Res"},{"issue":"1","key":"4444_CR115","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.prp.2018.10.013","volume":"215","author":"CB Hua","year":"2019","unstructured":"Hua CB, Song SB, Ma HL, Li XZ. MiR-1-5p is down-regulated in gallbladder carcinoma and suppresses cell proliferation, migration and invasion by targeting Notch2. Pathol Res Pract. 2019;215(1):200\u20138.","journal-title":"Pathol Res Pract"},{"issue":"11","key":"4444_CR116","first-page":"2448","volume":"6","author":"Y Huang","year":"2016","unstructured":"Huang Y, Wu Y, Dong J, Han D, Yang S, Jiang L. MicroRNA-133a-3p exerts inhibitory effects on gallbladder carcinoma via targeting RBPJ. Am J Cancer Res. 2016;6(11):2448\u201362.","journal-title":"Am J Cancer Res"},{"issue":"5","key":"4444_CR117","first-page":"375","volume":"70","author":"AJ Grossberg","year":"2020","unstructured":"Grossberg AJ, Chu LC, Deig CR, Fishman EK, Hwang WL, Maitra A, et al. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma. CA Cancer J Clin. 2020;70(5):375\u2013403.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4444_CR118","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13578-024-01213-9","volume":"14","author":"C Luo","year":"2024","unstructured":"Luo C, Yu Y, Zhu J, Chen L, Li D, Peng X, et al. Deubiquitinase PSMD7 facilitates pancreatic cancer progression through activating Nocth1 pathway via modifying SOX2 degradation. Cell Biosci. 2024;14(1):35.","journal-title":"Cell Biosci"},{"issue":"11","key":"4444_CR119","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41419-022-05379-3","volume":"13","author":"S Chen","year":"2022","unstructured":"Chen S, Cai K, Zheng D, Liu Y, Li L, He Z, et al. RHBDL2 promotes the proliferation, migration, and invasion of pancreatic cancer by stabilizing the N1ICD via the OTUD7B and activating the Notch signaling pathway. Cell Death Dis. 2022;13(11):945.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4444_CR120","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41421-023-00592-6","volume":"9","author":"S Zhai","year":"2023","unstructured":"Zhai S, Lin J, Ji Y, Zhang R, Zhang Z, Cao Y, et al. A microprotein N1DARP encoded by LINC00261 promotes Notch1 intracellular domain (N1ICD) degradation via disrupting USP10-N1ICD interaction to inhibit chemoresistance in Notch1-hyperactivated pancreatic cancer. Cell Discov. 2023;9(1):95.","journal-title":"Cell Discov"},{"issue":"1","key":"4444_CR121","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1186\/s12935-021-02189-z","volume":"21","author":"J Xu","year":"2021","unstructured":"Xu J, Xu W, Yang X, Liu Z, Zhao Y, Sun Q. LncRNA MIR99AHG mediated by FOXA1 modulates NOTCH2\/Notch signaling pathway to accelerate pancreatic cancer through sponging miR-3129-5p and recruiting ELAVL1. Cancer Cell Int. 2021;21(1):674.","journal-title":"Cancer Cell Int"},{"issue":"6","key":"4444_CR122","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41388-024-03226-7","volume":"44","author":"WC Chung","year":"2025","unstructured":"Chung WC, Zhang S, Atfi A, Xu K. Lfng-expressing centroacinar cell is a unique cell-of-origin for p53 deficient pancreatic cancer. Oncogene. 2025;44(6):348\u201362.","journal-title":"Oncogene"},{"issue":"1","key":"4444_CR123","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12929-023-00937-z","volume":"30","author":"YC Tsai","year":"2023","unstructured":"Tsai YC, Cheng KH, Jiang SS, Hawse JR, Chuang SE, Chen SL, et al. Kr\u00fcppel-like factor 10 modulates stem cell phenotypes of pancreatic adenocarcinoma by transcriptionally regulating notch receptors. J Biomed Sci. 2023;30(1):39.","journal-title":"J Biomed Sci"},{"issue":"12","key":"4444_CR124","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/s41419-024-07324-y","volume":"15","author":"S Chen","year":"2024","unstructured":"Chen S, He Z, Cai K, Zhang Y, Zhu H, Pang C, et al. TRIM59\/RBPJ positive feedback circuit confers gemcitabine resistance in pancreatic cancer by activating the Notch signaling pathway. Cell Death Dis. 2024;15(12):932.","journal-title":"Cell Death Dis"},{"issue":"10","key":"4444_CR125","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41419-024-07110-w","volume":"15","author":"Q Jia","year":"2024","unstructured":"Jia Q, Zhu Y, Yao H, Yin Y, Duan Z, Zheng J, et al. Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9\/ NOTCH\/ DDR axis in pancreatic ductal adenocarcinoma. Cell Death Dis. 2024;15(10):767.","journal-title":"Cell Death Dis"},{"key":"4444_CR126","doi-asserted-by":"publisher","first-page":"719855","DOI":"10.3389\/fonc.2021.719855","volume":"11","author":"D Cheng","year":"2021","unstructured":"Cheng D, Fan J, Qin K, Zhou Y, Yang J, Ma Y, et al. LncRNA SNHG7 Regulates Mesenchymal Stem Cell Through the Notch1\/Jagged1\/Hes-1 Signaling Pathway and Influences Folfirinox Resistance in Pancreatic Cancer. Front Oncol. 2021;11:719855.","journal-title":"Front Oncol"},{"key":"4444_CR127","doi-asserted-by":"crossref","unstructured":"Palamaris K, Felekouras E, Sakellariou S. Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance. Cancers (Basel). 2021;13(21):5532.","DOI":"10.3390\/cancers13215532"},{"issue":"1","key":"4444_CR128","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1158\/2326-6066.CIR-23-0037","volume":"12","author":"W Yan","year":"2024","unstructured":"Yan W, Menjivar RE, Bonilla ME, Steele NG, Kemp SB, Du W, et al. Notch Signaling Regulates Immunosuppressive Tumor-Associated Macrophage Function in Pancreatic Cancer. Cancer Immunol Res. 2024;12(1):91\u2013106.","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"4444_CR129","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1158\/0008-5472.CAN-20-0256","volume":"81","author":"Y Geng","year":"2021","unstructured":"Geng Y, Fan J, Chen L, Zhang C, Qu C, Qian L, et al. A Notch-Dependent Inflammatory Feedback Circuit between Macrophages and Cancer Cells Regulates Pancreatic Cancer Metastasis. Cancer Res. 2021;81(1):64\u201376.","journal-title":"Cancer Res"},{"key":"4444_CR130","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2020.02.039","volume":"481","author":"K Ogawa","year":"2020","unstructured":"Ogawa K, Lin Q, Li L, Bai X, Chen X, Chen H, et al. Prometastatic secretome trafficking via exosomes initiates pancreatic cancer pulmonary metastasis. Cancer Lett. 2020;481:63\u201375.","journal-title":"Cancer Lett"},{"issue":"12","key":"4444_CR131","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","volume":"16","author":"N Keum","year":"2019","unstructured":"Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16(12):713\u201332.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"4444_CR132","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000543921","volume":"106","author":"T Matsuda","year":"2025","unstructured":"Matsuda T, Fujimoto A, Igarashi Y. Colorectal Cancer: Epidemiology, Risk Factors, and Public Health Strategies. Digestion. 2025;106(2):91\u20139.","journal-title":"Digestion"},{"issue":"3","key":"4444_CR133","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4444_CR134","doi-asserted-by":"publisher","first-page":"15999","DOI":"10.1038\/s41598-023-42234-7","volume":"13","author":"L Wang","year":"2023","unstructured":"Wang L, Gu W, Zou B, Kalady M, Xin W, Zhou L. Loss of HES1 expression is associated with extracellular matrix remodeling and tumor immune suppression in KRAS mutant colon adenocarcinomas. Sci Rep. 2023;13(1):15999.","journal-title":"Sci Rep"},{"issue":"9","key":"4444_CR135","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s12032-025-02958-0","volume":"42","author":"X Wang","year":"2025","unstructured":"Wang X, Wen X, Hu X, Niu W, Guo G, Yang F, et al. ALDH1A1 promotes colorectal cancer metastasis through activating the notch signaling pathway. Med Oncol. 2025;42(9):403.","journal-title":"Med Oncol"},{"key":"4444_CR136","doi-asserted-by":"crossref","unstructured":"Zeng X, Jiang L, Li H, Wang J, He X. MC1R contributes to ferroptosis resistance and tumor aggressiveness in colorectal cancer by activating Notch signaling. Cancer Gene Ther. 2025;33(1):26\u201338.","DOI":"10.1038\/s41417-025-00942-4"},{"issue":"1","key":"4444_CR137","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12935-023-03026-1","volume":"23","author":"Z Chen","year":"2023","unstructured":"Chen Z, Cheng H, Zhang J, Jiang D, Chen G, Yan S, et al. Hsa_circRNA_102051 regulates colorectal cancer proliferation and metastasis by mediating Notch pathway. Cancer Cell Int. 2023;23(1):230.","journal-title":"Cancer Cell Int"},{"issue":"3","key":"4444_CR138","doi-asserted-by":"publisher","first-page":"e2405758","DOI":"10.1002\/advs.202405758","volume":"12","author":"Z Xiang","year":"2025","unstructured":"Xiang Z, Wang Y, Ma X, Song S, He Y, Zhou J, et al. Targeting the NOTCH2\/ADAM10\/TCF7L2 Axis-Mediated Transcriptional Regulation of Wnt Pathway Suppresses Tumor Growth and Enhances Chemosensitivity in Colorectal Cancer. Adv Sci (Weinh). 2025;12(3):e2405758.","journal-title":"Adv Sci (Weinh)"},{"key":"4444_CR139","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ijbiomac.2018.05.151","volume":"117","author":"Y Jin","year":"2018","unstructured":"Jin Y, Wang M, Hu H, Huang Q, Chen Y, Wang G. Overcoming stemness and chemoresistance in colorectal cancer through miR-195-5p-modulated inhibition of notch signaling. Int J Biol Macromol. 2018;117:445\u201353.","journal-title":"Int J Biol Macromol"},{"key":"4444_CR140","doi-asserted-by":"publisher","first-page":"101013","DOI":"10.1016\/j.jbior.2024.101013","volume":"91","author":"DC George","year":"2024","unstructured":"George DC, Bertrand FE, Sigounas G. Notch-3 affects chemoresistance in colorectal cancer via DNA base excision repair enzymes. Adv Biol Regul. 2024;91:101013.","journal-title":"Adv Biol Regul"},{"key":"4444_CR141","doi-asserted-by":"publisher","first-page":"1741261","DOI":"10.3389\/fimmu.2026.1741261","volume":"17","author":"Q Ma","year":"2026","unstructured":"Ma Q, Xu S, Ma N, Li K, Liu Y, Ma F. NOTCH3 attenuates cytotoxicity via RBPJ-dependent PVR upregulation to influence immunotherapy outcomes in colorectal cancer. Front Immunol. 2026;17:1741261.","journal-title":"Front Immunol"},{"issue":"1","key":"4444_CR142","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12885-023-10526-w","volume":"23","author":"K Huang","year":"2023","unstructured":"Huang K, Luo W, Fang J, Yu C, Liu G, Yuan X, et al. Notch3 signaling promotes colorectal tumor growth by enhancing immunosuppressive cells infiltration in the microenvironment. BMC Cancer. 2023;23(1):55.","journal-title":"BMC Cancer"},{"issue":"14","key":"4444_CR143","doi-asserted-by":"publisher","first-page":"6095","DOI":"10.7150\/thno.44147","volume":"10","author":"TT Liao","year":"2020","unstructured":"Liao TT, Lin CC, Jiang JK, Yang SH, Teng HW, Yang MH. Harnessing stemness and PD-L1 expression by AT-rich interaction domain-containing protein 3B in colorectal cancer. Theranostics. 2020;10(14):6095\u2013112.","journal-title":"Theranostics"},{"issue":"7","key":"4444_CR144","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/s41418-025-01450-6","volume":"32","author":"L Liu","year":"2025","unstructured":"Liu L, Han F, Deng M, Han Q, Lai M, Zhang H. Crosstalk between GLTSCR1-deficient endothelial cells and tumour cells promotes colorectal cancer development by activating the Notch pathway. Cell Death Differ. 2025;32(7):1231\u201343.","journal-title":"Cell Death Differ"},{"issue":"1","key":"4444_CR145","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12964-025-02395-6","volume":"23","author":"I Carmi","year":"2025","unstructured":"Carmi I, Orosz A, Hajd\u00f3 S, Ze\u00f6ld A, Heged\u0171s T, Kelemen-Gy\u0151ri D, et al. The aggressive colorectal cancer subtype marker HTR2B has a dual role depending on the tumor microenvironment. Cell Commun Signal. 2025;23(1):403.","journal-title":"Cell Commun Signal"},{"issue":"12","key":"4444_CR146","doi-asserted-by":"publisher","first-page":"e2105222","DOI":"10.1002\/advs.202105222","volume":"9","author":"H Liu","year":"2022","unstructured":"Liu H, Du J, Chao S, Li S, Cai H, Zhang H, et al. Fusobacterium nucleatum Promotes Colorectal Cancer Cell to Acquire Stem Cell-Like Features by Manipulating Lipid Droplet-Mediated Numb Degradation. Adv Sci (Weinh). 2022;9(12):e2105222.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"4444_CR147","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41416-024-02892-4","volume":"132","author":"S Poghosyan","year":"2025","unstructured":"Poghosyan S, Frenkel N, van den Bent L, Raats D, Spaapen T, Laoukili J, et al. VEGF-C propagates \u2018onward\u2019 colorectal cancer metastasis from liver to lung. Br J Cancer. 2025;132(1):69\u201380.","journal-title":"Br J Cancer"},{"issue":"3","key":"4444_CR148","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1136\/gutjnl-2023-330243","volume":"73","author":"R Li","year":"2024","unstructured":"Li R, Liu X, Huang X, Zhang D, Chen Z, Zhang J, et al. Single-cell transcriptomic analysis deciphers heterogenous cancer stem-like cells in colorectal cancer and their organ-specific metastasis. Gut. 2024;73(3):470\u201384.","journal-title":"Gut"},{"key":"4444_CR149","doi-asserted-by":"publisher","first-page":"901559","DOI":"10.3389\/fphar.2022.901559","volume":"13","author":"G Tong","year":"2022","unstructured":"Tong G, Peng T, Chen Y, Sha L, Dai H, Xiang Y, et al. Effects of GLP-1 Receptor Agonists on Biological Behavior of Colorectal Cancer Cells by Regulating PI3K\/AKT\/mTOR Signaling Pathway. Front Pharmacol. 2022;13:901559.","journal-title":"Front Pharmacol"},{"issue":"1","key":"4444_CR150","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41536-021-00139-x","volume":"6","author":"S Lee","year":"2021","unstructured":"Lee S, Remark LH, Josephson AM, Leclerc K, Lopez EM, Kirby DJ, et al. Notch-Wnt signal crosstalk regulates proliferation and differentiation of osteoprogenitor cells during intramembranous bone healing. NPJ Regenerative Med. 2021;6(1):29.","journal-title":"NPJ Regenerative Med"},{"key":"4444_CR151","doi-asserted-by":"publisher","first-page":"100957","DOI":"10.1016\/j.jbior.2023.100957","volume":"88","author":"AG Clark","year":"2023","unstructured":"Clark AG, Bertrand FE, Sigounas G. A potential requirement for Smad3 phosphorylation in Notch-mediated EMT in colon cancer. Adv Biol Regul. 2023;88:100957.","journal-title":"Adv Biol Regul"},{"key":"4444_CR152","doi-asserted-by":"publisher","first-page":"101669","DOI":"10.1016\/j.tranon.2023.101669","volume":"32","author":"S Ghosh","year":"2023","unstructured":"Ghosh S, Mitra P, Saha U, Nandi R, Jena S, Ghosh A, et al. NOTCH pathway inactivation reprograms stem-like oral cancer cells to JAK-STAT dependent state and provides the opportunity of synthetic lethality. Translational Oncol. 2023;32:101669.","journal-title":"Translational Oncol"},{"issue":"16","key":"4444_CR153","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1182\/blood-2013-08-355818","volume":"123","author":"C Lobry","year":"2014","unstructured":"Lobry C, Oh P, Mansour MR, Look AT, Aifantis I. Notch signaling: switching an oncogene to a tumor suppressor. Blood. 2014;123(16):2451\u20139.","journal-title":"Blood"},{"key":"4444_CR154","doi-asserted-by":"crossref","unstructured":"Misiorek JO, Przybyszewska-Podstawka A, Ka\u0142afut J, Paziewska B, Rolle K, Rivero-M\u00fcller A et al. Context Matters: NOTCH Signatures and Pathway in Cancer Progression and Metastasis. Cells. 2021;10(1):94.","DOI":"10.3390\/cells10010094"},{"issue":"4","key":"4444_CR155","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1159\/000440954","volume":"62","author":"EK Parkinson","year":"2016","unstructured":"Parkinson EK, James EL, Prime SS. Senescence-Derived Extracellular Molecules as Modulators of Oral Cancer Development: A Mini-Review. Gerontology. 2016;62(4):417\u201324.","journal-title":"Gerontology"},{"issue":"12","key":"4444_CR156","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s12032-021-01593-9","volume":"38","author":"K Nigam","year":"2021","unstructured":"Nigam K, Srivastav RK. Notch signaling in oral pre-cancer and oral cancer. Med Oncol. 2021;38(12):139.","journal-title":"Med Oncol"},{"issue":"7","key":"4444_CR157","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1158\/2159-8290.CD-12-0537","volume":"3","author":"CR Pickering","year":"2013","unstructured":"Pickering CR, Zhang J, Yoo SY, Bengtsson L, Moorthy S, Neskey DM, et al. Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discov. 2013;3(7):770\u201381.","journal-title":"Cancer Discov"},{"issue":"8","key":"4444_CR158","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41419-020-02873-4","volume":"11","author":"Y Zheng","year":"2020","unstructured":"Zheng Y, Song A, Wang C, Zhang W, Liang D, Ding X, et al. Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma. Cell Death Dis. 2020;11(8):615.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4444_CR159","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1038\/s41467-020-19401-9","volume":"11","author":"I Sequeira","year":"2020","unstructured":"Sequeira I, Rashid M, Tom\u00e1s IM, Williams MJ, Graham TA, Adams DJ, et al. Genomic landscape and clonal architecture of mouse oral squamous cell carcinomas dictate tumour ecology. Nat Commun. 2020;11(1):5671.","journal-title":"Nat Commun"},{"issue":"2","key":"4444_CR160","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.yexcr.2018.09.019","volume":"372","author":"W Sawangarun","year":"2018","unstructured":"Sawangarun W, Mandasari M, Aida J, Morita KI, Kayamori K, Ikeda T, et al. Loss of Notch1 predisposes oro-esophageal epithelium to tumorigenesis. Exp Cell Res. 2018;372(2):129\u201340.","journal-title":"Exp Cell Res"},{"issue":"3","key":"4444_CR161","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nrc.2016.145","volume":"17","author":"CS Nowell","year":"2017","unstructured":"Nowell CS, Radtke F. Notch as a tumour suppressor. Nat Rev Cancer. 2017;17(3):145\u201359.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"4444_CR162","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1177\/0022034518760297","volume":"97","author":"T Fukusumi","year":"2018","unstructured":"Fukusumi T, Califano JA. The NOTCH Pathway in Head and Neck Squamous Cell Carcinoma. J Dent Res. 2018;97(6):645\u201353.","journal-title":"J Dent Res"},{"issue":"1","key":"4444_CR163","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bjorl.2017.09.005","volume":"85","author":"MK Harishankar","year":"2019","unstructured":"Harishankar MK, Mohan AM, Krishnan AV. Downregulation of Notch4 - a prognostic marker in distinguishing oral verrucous carcinoma from oral squamous cell carcinoma. Braz J Otorhinolaryngol. 2019;85(1):11\u20136.","journal-title":"Braz J Otorhinolaryngol"},{"issue":"1","key":"4444_CR164","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12943-018-0857-2","volume":"17","author":"CH Yeh","year":"2018","unstructured":"Yeh CH, Bellon M, Nicot C. FBXW7: a critical tumor suppressor of human cancers. Mol Cancer. 2018;17(1):115.","journal-title":"Mol Cancer"},{"issue":"1","key":"4444_CR165","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12876-017-0616-7","volume":"17","author":"MR Li","year":"2017","unstructured":"Li MR, Zhu CC, Ling TL, Zhang YQ, Xu J, Zhao EH, et al. FBXW7 expression is associated with prognosis and chemotherapeutic outcome in Chinese patients with gastric adenocarcinoma. BMC Gastroenterol. 2017;17(1):60.","journal-title":"BMC Gastroenterol"},{"issue":"8","key":"4444_CR166","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.neo.2019.06.003","volume":"21","author":"WC Chung","year":"2019","unstructured":"Chung WC, Zhou Y, Atfi A, Xu K. Downregulation of Notch Signaling in Kras-Induced Gastric Metaplasia. Neoplasia. 2019;21(8):810\u201321.","journal-title":"Neoplasia"},{"key":"4444_CR167","doi-asserted-by":"crossref","unstructured":"Chung WC, Challagundla L, Zhou Y, Li M, Atfi A, Xu K. Loss of Jag1 cooperates with oncogenic Kras to induce pancreatic cystic neoplasms. Life Sci Alliance. 2021;4(2):e201900503.","DOI":"10.26508\/lsa.201900503"},{"issue":"5","key":"4444_CR168","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.7150\/thno.48739","volume":"11","author":"G Song","year":"2021","unstructured":"Song G, Zhu X, Xuan Z, Zhao L, Dong H, Chen J, et al. Hypermethylation of GNA14 and its tumor-suppressive role in hepatitis B virus-related hepatocellular carcinoma. Theranostics. 2021;11(5):2318\u201333.","journal-title":"Theranostics"},{"issue":"12","key":"4444_CR169","doi-asserted-by":"publisher","first-page":"4840","DOI":"10.1158\/0008-5472.CAN-10-0269","volume":"70","author":"YC Wang","year":"2010","unstructured":"Wang YC, He F, Feng F, Liu XW, Dong GY, Qin HY, et al. Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses. Cancer Res. 2010;70(12):4840\u20139.","journal-title":"Cancer Res"},{"issue":"17","key":"4444_CR170","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.1158\/0008-5472.CAN-18-0052","volume":"78","author":"PF Cheung","year":"2018","unstructured":"Cheung PF, Neff F, Neander C, Bazarna A, Savvatakis K, Liffers ST, et al. Notch-Induced Myeloid Reprogramming in Spontaneous Pancreatic Ductal Adenocarcinoma by Dual Genetic Targeting. Cancer Res. 2018;78(17):4997\u20135010.","journal-title":"Cancer Res"},{"key":"4444_CR171","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.2147\/JIR.S394894","volume":"16","author":"A Lin","year":"2023","unstructured":"Lin A, Yao J, Cheng Q, Liu Z, Luo P, Zhang J. Mutations Status of NOTCH Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colorectal Cancer. J Inflamm Res. 2023;16:1693\u2013709.","journal-title":"J Inflamm Res"},{"issue":"3","key":"4444_CR172","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1158\/2326-6066.CIR-20-0428","volume":"9","author":"L Wang","year":"2021","unstructured":"Wang L, Yu S, Chan ER, Chen KY, Liu C, Che D, et al. Notch-Regulated Dendritic Cells Restrain Inflammation-Associated Colorectal Carcinogenesis. Cancer Immunol Res. 2021;9(3):348\u201361.","journal-title":"Cancer Immunol Res"},{"key":"4444_CR173","doi-asserted-by":"crossref","unstructured":"Chen D, Gu X, Liu J, Xu L, Ye Z, Gao P et al. Notch signaling in the tumor microenvironment: recent advances and targeted therapeutics. Mol Cancer. 2026;25(1):50.","DOI":"10.1186\/s12943-025-02555-9"},{"issue":"4","key":"4444_CR174","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41571-019-0293-2","volume":"17","author":"JA Clara","year":"2020","unstructured":"Clara JA, Monge C, Yang Y, Takebe N. Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update. Nat Rev Clin Oncol. 2020;17(4):204\u201332.","journal-title":"Nat Rev Clin Oncol"},{"key":"4444_CR175","doi-asserted-by":"publisher","first-page":"216647","DOI":"10.1016\/j.canlet.2024.216647","volume":"585","author":"J Sun","year":"2024","unstructured":"Sun J, Dong M, Xiang X, Zhang S, Wen D. Notch signaling and targeted therapy in non-small cell lung cancer. Cancer Lett. 2024;585:216647.","journal-title":"Cancer Lett"},{"issue":"2","key":"4444_CR176","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.pharmthera.2013.09.005","volume":"141","author":"N Takebe","year":"2014","unstructured":"Takebe N, Nguyen D, Yang SX. Targeting notch signaling pathway in cancer: clinical development advances and challenges. Pharmacol Ther. 2014;141(2):140\u20139.","journal-title":"Pharmacol Ther"},{"key":"4444_CR177","doi-asserted-by":"crossref","unstructured":"Erkert L, Kabisch M, Gamez-Belmonte R, Gonzalez-Acera M, Patankar JV, Sch\u00f6del L et al. Pharmacological inhibitors of the gamma-secretase enzyme complex disrupt epithelial cell function triggering colitis in mice. J Crohns Colitis. 2025;19(7): jjaf096.","DOI":"10.1093\/ecco-jcc\/jjaf096"},{"issue":"8","key":"4444_CR178","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1158\/1078-0432.CCR-21-3874","volume":"28","author":"MM Gounder","year":"2022","unstructured":"Gounder MM, Rosenbaum E, Wu N, Dickson MA, Sheikh TN, D\u2019Angelo SP, et al. A Phase Ib\/II Randomized Study of RO4929097, a Gamma-Secretase or Notch Inhibitor with or without Vismodegib, a Hedgehog Inhibitor, in Advanced Sarcoma. Clin Cancer Res. 2022;28(8):1586\u201394.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4444_CR179","doi-asserted-by":"publisher","first-page":"28071","DOI":"10.1038\/s41598-024-79883-1","volume":"14","author":"X Duan","year":"2024","unstructured":"Duan X, Wu R, Zhang M, Li K, Yu L, Sun H, et al. The heterogeneity of NOTCH1 to tumor immune infiltration in pan-cancer. Sci Rep. 2024;14(1):28071.","journal-title":"Sci Rep"},{"key":"4444_CR180","doi-asserted-by":"publisher","first-page":"149761","DOI":"10.1016\/j.gene.2025.149761","volume":"969","author":"RS Sidhu","year":"2025","unstructured":"Sidhu RS, Guo S, Wang G, Liu M. Role of Notch and its oncogenic signaling crosstalk in glioma and glioma stem cells. Gene. 2025;969:149761.","journal-title":"Gene"},{"issue":"1","key":"4444_CR181","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/hep.30816","volume":"71","author":"CJ O\u2019Rourke","year":"2020","unstructured":"O\u2019Rourke CJ, Matter MS, Nepal C, Caetano-Oliveira R, Ton PT, Factor VM, et al. Identification of a Pan-Gamma-Secretase Inhibitor Response Signature for Notch-Driven Cholangiocarcinoma. Hepatology. 2020;71(1):196\u2013213.","journal-title":"Hepatology"},{"issue":"2","key":"4444_CR182","doi-asserted-by":"publisher","first-page":"e298","DOI":"10.1002\/onco.13595","volume":"26","author":"P L\u00f3pez-Nieva","year":"2021","unstructured":"L\u00f3pez-Nieva P, Gonz\u00e1lez-S\u00e1nchez L, Cobos-Fern\u00e1ndez M, C\u00f3rdoba R, Santos J, Fern\u00e1ndez-Piqueras J. More Insights on the Use of \u03b3-Secretase Inhibitors in Cancer Treatment. Oncologist. 2021;26(2):e298\u2013305.","journal-title":"Oncologist"},{"issue":"12","key":"4444_CR183","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1038\/s44321-024-00161-8","volume":"16","author":"M Fournier","year":"2024","unstructured":"Fournier M, Javary J, Roh V, Fournier N, Radtke F. Reciprocal inhibition of NOTCH and SOX2 shapes tumor cell plasticity and therapeutic escape in triple-negative breast cancer. EMBO Mol Med. 2024;16(12):3184\u2013217.","journal-title":"EMBO Mol Med"},{"issue":"4","key":"4444_CR184","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1124\/dmd.109.030841","volume":"38","author":"P Yi","year":"2010","unstructured":"Yi P, Hadden C, Kulanthaivel P, Calvert N, Annes W, Brown T, et al. Disposition and metabolism of semagacestat, a {gamma}-secretase inhibitor, in humans. Drug Metab Dispos. 2010;38(4):554\u201365.","journal-title":"Drug Metab Dispos"},{"key":"4444_CR185","doi-asserted-by":"publisher","first-page":"125142","DOI":"10.1016\/j.ijpharm.2024.125142","volume":"670","author":"M Kumari","year":"2025","unstructured":"Kumari M, Piyongsola, Ravi Naik M, Singh Rathore H, Kumar Shukla A, Iqbal Dar A, et al. Targeted delivery of DAPT using dual antibody functionalized solid lipid nanoparticles for enhanced anti-tumour activity against triple negative breast cancer. Int J Pharm. 2025;670:125142.","journal-title":"Int J Pharm"},{"key":"4444_CR186","doi-asserted-by":"crossref","unstructured":"Wang H, Zheng T, Xu D, Sun C, Huang D, Liu X. Targeting DLL3: Innovative Strategies for Tumor Treatment. Pharmaceutics. 2025;17(4):520.","DOI":"10.3390\/pharmaceutics17040520"},{"issue":"1","key":"4444_CR187","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12943-023-01839-2","volume":"22","author":"L An","year":"2023","unstructured":"An L, Li M, Jia Q. Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma. Mol Cancer. 2023;22(1):140.","journal-title":"Mol Cancer"},{"issue":"5","key":"4444_CR188","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00432-020-03493-3","volume":"147","author":"H Zhang","year":"2021","unstructured":"Zhang H, Si J, Yue J, Ma S. The mechanisms and reversal strategies of tumor radioresistance in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol. 2021;147(5):1275\u201386.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"12","key":"4444_CR189","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1158\/0008-5472.CAN-20-3892","volume":"81","author":"AC Mueller","year":"2021","unstructured":"Mueller AC, Piper M, Goodspeed A, Bhuvane S, Williams JS, Bhatia S, et al. Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer. Cancer Res. 2021;81(12):3255\u201369.","journal-title":"Cancer Res"},{"issue":"2","key":"4444_CR190","doi-asserted-by":"publisher","first-page":"105962","DOI":"10.1016\/j.isci.2023.105962","volume":"26","author":"R Coppo","year":"2023","unstructured":"Coppo R, Kondo J, Iida K, Okada M, Onuma K, Tanaka Y, et al. Distinct but interchangeable subpopulations of colorectal cancer cells with different growth fates and drug sensitivity. iScience. 2023;26(2):105962.","journal-title":"iScience"},{"issue":"1","key":"4444_CR191","doi-asserted-by":"publisher","first-page":"20230678","DOI":"10.1515\/med-2023-0678","volume":"18","author":"X Wang","year":"2023","unstructured":"Wang X, Zheng D, Wang C, Chen W. Knockdown of circ_0005615 enhances the radiosensitivity of colorectal cancer by regulating the miR-665\/NOTCH1 axis. Open Med (Wars). 2023;18(1):20230678.","journal-title":"Open Med (Wars)"},{"key":"4444_CR192","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.bbrc.2022.10.104","volume":"638","author":"R Li","year":"2023","unstructured":"Li R, Qin J, Wang Z, Lv F, Guo J, Zhu H, et al. Dioscin reduced chemoresistance for colon cancer and analysis of sensitizing targets. Biochem Biophys Res Commun. 2023;638:94\u2013102.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"4444_CR193","doi-asserted-by":"publisher","first-page":"152964","DOI":"10.1016\/j.prp.2020.152964","volume":"216","author":"Q Zhao","year":"2020","unstructured":"Zhao Q, Zhuang K, Han K, Tang H, Wang Y, Si W, et al. Silencing DVL3 defeats MTX resistance and attenuates stemness via Notch Signaling Pathway in colorectal cancer. Pathol Res Pract. 2020;216(8):152964.","journal-title":"Pathol Res Pract"},{"issue":"7","key":"4444_CR194","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41419-018-0804-6","volume":"9","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Li D, Jiang Q, Cao S, Sun H, Chai Y, et al. Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells. Cell Death Dis. 2018;9(7):743.","journal-title":"Cell Death Dis"},{"key":"4444_CR195","doi-asserted-by":"crossref","unstructured":"Sun L, He M, Li F, Wu D, Zheng P, Zhang C et al. Oxyberberine sensitizes liver cancer cells to sorafenib via inhibiting NOTCH1-USP7-c-Myc pathway. Hepatol Commun. 2024;8(4):e0405.","DOI":"10.1097\/HC9.0000000000000405"},{"key":"4444_CR196","doi-asserted-by":"crossref","unstructured":"Xiang Z, Miao Q, Zhang J, Liu G, Xue S, Liu X et al. AB4 inhibits Notch signaling and promotes cancer cell apoptosis in liver cancer. Oncol Rep. 2021;45(6):112.","DOI":"10.3892\/or.2021.8063"},{"issue":"79","key":"4444_CR197","doi-asserted-by":"publisher","first-page":"34996","DOI":"10.18632\/oncotarget.26209","volume":"9","author":"X Yang","year":"2018","unstructured":"Yang X, Xia W, Chen L, Wu CX, Zhang CC, Olson P, et al. Synergistic antitumor effect of a \u03b3-secretase inhibitor PF-03084014 and sorafenib in hepatocellular carcinoma. Oncotarget. 2018;9(79):34996\u20135007.","journal-title":"Oncotarget"},{"issue":"1","key":"4444_CR198","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/HEP.0000000000000045","volume":"79","author":"M Cunningham","year":"2024","unstructured":"Cunningham M, Gupta R, Butler M. Checkpoint inhibitor hepatotoxicity: pathogenesis and management. Hepatology. 2024;79(1):198\u2013212.","journal-title":"Hepatology"},{"key":"4444_CR199","doi-asserted-by":"crossref","unstructured":"Montagner A, Arleo A, Suzzi F, D\u2019Assoro AB, Piscaglia F, Gramantieri L et al. Notch Signaling and PD-1\/PD-L1 Interaction in Hepatocellular Carcinoma: Potentialities of Combined Therapies. Biomolecules. 2024;14(12):1581.","DOI":"10.3390\/biom14121581"},{"issue":"5","key":"4444_CR200","doi-asserted-by":"publisher","first-page":"e6985","DOI":"10.1002\/cam4.6985","volume":"13","author":"K Ogi","year":"2024","unstructured":"Ogi K, Iwamoto T, Sasaya T, Nishiyama K, Tokura T, Sasaki T, et al. Notch signaling genes and CD8(+) T-cell dynamics: Their contribution to immune-checkpoint inhibitor therapy in oral squamous cell carcinoma: A retrospective study. Cancer Med. 2024;13(5):e6985.","journal-title":"Cancer Med"},{"issue":"1","key":"4444_CR201","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s10238-025-01825-6","volume":"25","author":"Y Luo","year":"2025","unstructured":"Luo Y, Wang R, Xu Y, He M, Zhou Q, Wang G, et al. Notch pathway defines an aggressive and immune-suppressive phenotype associated with checkpoint inhibitor resistance in pan-gastrointestinal adenocarcinomas. Clin Exp Med. 2025;25(1):340.","journal-title":"Clin Exp Med"},{"issue":"1","key":"4444_CR202","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41392-022-01058-z","volume":"7","author":"GH Ran","year":"2022","unstructured":"Ran GH, Lin YQ, Tian L, Zhang T, Yan DM, Yu JH, et al. Natural killer cell homing and trafficking in tissues and tumors: from biology to application. Signal Transduct Target Ther. 2022;7(1):205.","journal-title":"Signal Transduct Target Ther"},{"issue":"25","key":"4444_CR203","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1182\/blood-2017-02-769208","volume":"129","author":"RA Gardner","year":"2017","unstructured":"Gardner RA, Finney O, Annesley C, Brakke H, Summers C, Leger K, et al. Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults. Blood. 2017;129(25):3322\u201331.","journal-title":"Blood"},{"issue":"12","key":"4444_CR204","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.tips.2023.09.011","volume":"44","author":"E Medina","year":"2023","unstructured":"Medina E, Perez DH, Antfolk D, Luca VC. New tricks for an old pathway: emerging Notch-based biotechnologies and therapeutics. Trends Pharmacol Sci. 2023;44(12):934\u201348.","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"4444_CR205","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cell.2016.09.011","volume":"167","author":"KT Roybal","year":"2016","unstructured":"Roybal KT, Williams JZ, Morsut L, Rupp LJ, Kolinko I, Choe JH, et al. Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors. Cell. 2016;167(2):419\u2013e432416.","journal-title":"Cell"},{"key":"4444_CR206","doi-asserted-by":"crossref","unstructured":"Choe JH, Watchmaker PB, Simic MS, Gilbert RD, Li AW, Krasnow NA et al. SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma. Sci Transl Med. 2021;13(591):eabe7378.","DOI":"10.1126\/scitranslmed.abe7378"},{"issue":"4","key":"4444_CR207","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.3390\/cimb46040183","volume":"46","author":"A Ahmadnia","year":"2024","unstructured":"Ahmadnia A, Mohammadi S, Yamchi A, Kalani MR, Farazmandfar T, Khosravi A, et al. Augmenting the Antitumor Efficacy of Natural Killer Cells via SynNotch Receptor Engineering for Targeted IL-12 Secretion. Curr Issues Mol Biol. 2024;46(4):2931\u201345.","journal-title":"Curr Issues Mol Biol"},{"key":"4444_CR208","doi-asserted-by":"crossref","unstructured":"Yan J, Xie Y, Liu Z, Yang Y, Zhou T. DLL4-targeted CAR-T therapy sensitizes neoadjuvant chemotherapy via eliminating cancer stem cells and reshaping immune microenvironment in HER2(+) breast cancer. J Immunother Cancer. 2024;12(11):e009636.","DOI":"10.1136\/jitc-2024-009636"},{"issue":"3","key":"4444_CR209","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/imm.13776","volume":"172","author":"F Nie","year":"2024","unstructured":"Nie F, Chen Y, Hu Y, Huang P, Shi X, Cai J, et al. TREM1\/DAP12 based novel multiple chain CAR-T cells targeting DLL3 show robust anti-tumour efficacy for small cell lung cancer. Immunology. 2024;172(3):362\u201374.","journal-title":"Immunology"},{"issue":"3","key":"4444_CR210","doi-asserted-by":"publisher","first-page":"200833","DOI":"10.1016\/j.omton.2024.200833","volume":"32","author":"P G\u0142owacki","year":"2024","unstructured":"G\u0142owacki P, Tr\u0119da C, Rieske P. Regulation of CAR transgene expression to design semiautonomous CAR-T. Mol Ther Oncol. 2024;32(3):200833.","journal-title":"Mol Ther Oncol"},{"key":"4444_CR211","doi-asserted-by":"publisher","first-page":"110708","DOI":"10.1016\/j.clim.2026.110708","volume":"285","author":"K Murod","year":"2026","unstructured":"Murod K, Saodat Y, Avazmetova I, Zokir R, Khalbayeva Z, Nozima K, et al. Strategies for enhancing specificity and efficacy of oncolytic viruses in cancer treatment. Clin Immunol (Orlando Fla). 2026;285:110708.","journal-title":"Clin Immunol (Orlando Fla)"},{"issue":"1","key":"4444_CR212","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13046-025-03358-y","volume":"44","author":"S Wang","year":"2025","unstructured":"Wang S, Kong L, Wang L, Zhuang Y, Guo C, Zhang Y, et al. Viral expression of NE\/PPE enhances anti-colorectal cancer efficacy of oncolytic adenovirus by promoting TAM M1 polarization to reverse insufficient effector memory\/effector CD8(+) T cell infiltration. J Exp Clin Cancer Res. 2025;44(1):97.","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"4444_CR213","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1158\/1078-0432.CCR-24-2498","volume":"31","author":"EJ West","year":"2025","unstructured":"West EJ, Sadoun A, Bendjama K, Erbs P, Smolenschi C, Cassier PA, et al. A Phase I Clinical Trial of Intrahepatic Artery Delivery of TG6002 in Combination with Oral 5-Fluorocytosine in Patients with Liver-Dominant Metastatic Colorectal Cancer. Clin Cancer Res. 2025;31(7):1243\u201356.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4444_CR214","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1186\/s12964-024-01888-0","volume":"22","author":"YY Wu","year":"2024","unstructured":"Wu YY, Wu FH, Chen IC, Liao TL, Munir M, Liu HJ. Oncolytic avian reovirus-sensitized tumor infiltrating CD8(+) T cells triggering immunogenic apoptosis in gastric cancer. Cell Commun Signal. 2024;22(1):514.","journal-title":"Cell Commun Signal"},{"key":"4444_CR215","doi-asserted-by":"publisher","first-page":"102151","DOI":"10.1016\/j.tranon.2024.102151","volume":"50","author":"Y Ju","year":"2024","unstructured":"Ju Y, Dai F, Wang Y, Ye Z, Li Y, Ju S, et al. Oncolytic vaccinia virus armed with 4-1BBL elicits potent and safe antitumor immunity and enhances the therapeutic efficiency of PD-1\/PD-L1 blockade in a pancreatic cancer model. Translational Oncol. 2024;50:102151.","journal-title":"Translational Oncol"},{"issue":"7","key":"4444_CR216","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1158\/1078-0432.CCR-21-2347","volume":"28","author":"Y Otani","year":"2022","unstructured":"Otani Y, Yoo JY, Lewis CT, Chao S, Swanner J, Shimizu T, et al. NOTCH-Induced MDSC Recruitment after oHSV Virotherapy in CNS Cancer Models Modulates Antitumor Immunotherapy. Clin Cancer Res. 2022;28(7):1460\u201373.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4444_CR217","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13045-023-01439-z","volume":"16","author":"X Li","year":"2023","unstructured":"Li X, Yan X, Wang Y, Kaur B, Han H, Yu J. The Notch signaling pathway: a potential target for cancer immunotherapy. J Hematol Oncol. 2023;16(1):45.","journal-title":"J Hematol Oncol"},{"issue":"18","key":"4444_CR218","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41388-025-03306-2","volume":"44","author":"Y Piao","year":"2025","unstructured":"Piao Y, Jung SN, Lim MA, Zheng S, Oh C, Jin YL, et al. The role of miR-92b-3p in notch signaling and monitoring of oral squamous cell carcinoma. Oncogene. 2025;44(18):1300\u201311.","journal-title":"Oncogene"},{"issue":"2","key":"4444_CR219","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10142-023-01041-z","volume":"23","author":"P Pandey","year":"2023","unstructured":"Pandey P, Suyal G, Aprajita PK, Sharma R. NGS-based profiling identifies miRNAs and pathways dysregulated in cisplatin-resistant esophageal cancer cells. Funct Integr Genomics. 2023;23(2):111.","journal-title":"Funct Integr Genomics"},{"key":"4444_CR220","doi-asserted-by":"publisher","first-page":"9175","DOI":"10.2147\/CMAR.S329419","volume":"13","author":"J Ma","year":"2021","unstructured":"Ma J, Zhao G, Du J, Li J, Lin G, Zhang J. LncRNA FENDRR Inhibits Gastric Cancer Cell Proliferation and Invasion via the miR-421\/SIRT3\/Notch-1 Axis. Cancer Manag Res. 2021;13:9175\u201387.","journal-title":"Cancer Manag Res"},{"issue":"8","key":"4444_CR221","first-page":"1239","volume":"40","author":"Z Wang","year":"2025","unstructured":"Wang Z, Wang L, Yin G, Li H, Zhang R, Feng Y, et al. Hsa_circ_0088036 promotes tumorigenesis and chemotherapy resistance in hepatocellular carcinoma via the miR-140-3p\/KIF2A axis. Histol Histopathol. 2025;40(8):1239\u201351.","journal-title":"Histol Histopathol"},{"issue":"1","key":"4444_CR222","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12885-023-11703-7","volume":"24","author":"J Ai","year":"2024","unstructured":"Ai J, Zhang W, Deng W, Yan L, Zhang L, Huang Z, et al. A hsa_circ_001726 axis regulated by E2F6 contributes to metastasis of hepatocellular carcinoma. BMC Cancer. 2024;24(1):14.","journal-title":"BMC Cancer"},{"key":"4444_CR223","doi-asserted-by":"publisher","first-page":"1355064","DOI":"10.3389\/fonc.2024.1355064","volume":"14","author":"S Jafari","year":"2024","unstructured":"Jafari S, Motedayyen H, Javadi P, Jamali K, Moradi Hasan-Abad A, Atapour A, et al. The roles of lncRNAs and miRNAs in pancreatic cancer: a focus on cancer development and progression and their roles as potential biomarkers. Front Oncol. 2024;14:1355064.","journal-title":"Front Oncol"},{"issue":"3","key":"4444_CR224","doi-asserted-by":"publisher","first-page":"e70038","DOI":"10.1002\/ccs3.70038","volume":"19","author":"P Yazdan Panah","year":"2025","unstructured":"Yazdan Panah P, Sadeghi A, Ghafouri-Fard S. Beyond linear: How circRNAs twist and turn Notch signaling. J Cell Commun Signal. 2025;19(3):e70038.","journal-title":"J Cell Commun Signal"},{"issue":"1","key":"4444_CR225","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1186\/s13046-019-1436-0","volume":"38","author":"Y Chen","year":"2019","unstructured":"Chen Y, Li Z, Zhang M, Wang B, Ye J, Zhang Y, et al. Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma. J Exp Clin Cancer Res. 2019;38(1):466.","journal-title":"J Exp Clin Cancer Res"},{"key":"4444_CR226","doi-asserted-by":"publisher","first-page":"38232","DOI":"10.1038\/srep38232","volume":"7","author":"Y Tang","year":"2017","unstructured":"Tang Y, Tang Y, Cheng YS. miR-34a inhibits pancreatic cancer progression through Snail1-mediated epithelial-mesenchymal transition and the Notch signaling pathway. Sci Rep. 2017;7:38232.","journal-title":"Sci Rep"},{"key":"4444_CR227","doi-asserted-by":"publisher","first-page":"111605","DOI":"10.1016\/j.cellsig.2025.111605","volume":"127","author":"AS Nadukkandy","year":"2025","unstructured":"Nadukkandy AS, Blaize B, Kumar CD, Mori G, Cordani M, Kumar LD. Non-coding RNAs as mediators of epithelial to mesenchymal transition in metastatic colorectal cancers. Cell Signal. 2025;127:111605.","journal-title":"Cell Signal"},{"issue":"4","key":"4444_CR228","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.21037\/tcr.2020.03.03","volume":"9","author":"Y Xiao","year":"2020","unstructured":"Xiao Y, Hu F, Li M, Mo L, Xu C, Wang X, et al. Interaction between linc01615 and miR-491-5p regulates the survival and metastasis of colorectal cancer cells. Translational cancer Res. 2020;9(4):2638\u201347.","journal-title":"Translational cancer Res"},{"issue":"2","key":"4444_CR229","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s10637-016-0407-y","volume":"35","author":"MS Beg","year":"2017","unstructured":"Beg MS, Brenner AJ, Sachdev J, Borad M, Kang YK, Stoudemire J, et al. Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors. Investig New Drugs. 2017;35(2):180\u20138.","journal-title":"Investig New Drugs"},{"issue":"11","key":"4444_CR230","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","volume":"122","author":"DS Hong","year":"2020","unstructured":"Hong DS, Kang YK, Borad M, Sachdev J, Ejadi S, Lim HY, et al. Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. Br J Cancer. 2020;122(11):1630\u20137.","journal-title":"Br J Cancer"},{"key":"4444_CR231","doi-asserted-by":"crossref","unstructured":"Seyhan AA. Trials and Tribulations of MicroRNA Therapeutics. Int J Mol Sci. 2024;25(3):1469.","DOI":"10.3390\/ijms25031469"},{"issue":"7","key":"4444_CR232","doi-asserted-by":"publisher","first-page":"e4133","DOI":"10.1002\/cbf.4133","volume":"42","author":"S Ilanchit Chenni","year":"2024","unstructured":"Ilanchit Chenni S, Suresh K, Theerthu A, Ahamed AAN, Pugazhendhi R, Vasu R. PLGA-Loaded Nedaplatin (PLGA-NDP) Inhibits 7,12-Dimethylbenz[a]anthracene (DMBA) Induced Oral Carcinogenesis via Modulating Notch Signaling Pathway and Induces Apoptosis in Experimental Hamster Model. Cell Biochem Funct. 2024;42(7):e4133.","journal-title":"Cell Biochem Funct"},{"issue":"39","key":"4444_CR233","doi-asserted-by":"publisher","first-page":"e02409","DOI":"10.1002\/advs.202502409","volume":"12","author":"H Cao","year":"2025","unstructured":"Cao H, Wang Q, Niu Y, Wang S, Jia H, Wang D, et al. Dual-Targeted Nanovesicles Induced Cancer Stem-Like Cell Differentiation to Sensitize Hepatocellular Carcinoma Radiotherapy. Adv Sci (Weinh). 2025;12(39):e02409.","journal-title":"Adv Sci (Weinh)"},{"key":"4444_CR234","doi-asserted-by":"publisher","first-page":"118458","DOI":"10.1016\/j.lfs.2020.118458","volume":"261","author":"MS Zeyada","year":"2020","unstructured":"Zeyada MS, Abdel-Rahman N, El-Karef A, Yahia S, El-Sherbiny IM, Eissa LA. Niclosamide-loaded polymeric micelles ameliorate hepatocellular carcinoma in vivo through targeting Wnt and Notch pathways. Life Sci. 2020;261:118458.","journal-title":"Life Sci"},{"key":"4444_CR235","doi-asserted-by":"crossref","unstructured":"Dilliard SA, Cheng Q, Siegwart DJ. On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles. Proc Natl Acad Sci U S A. 2021;118(52):e2109256118.","DOI":"10.1073\/pnas.2109256118"},{"issue":"1","key":"4444_CR236","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12645-024-00259-1","volume":"15","author":"D-d Li","year":"2024","unstructured":"Li D-d, Jin J-c, Liu X-w, Liu S-y, Ji F-j, Liu T. Nanoparticle delivery of si-Notch1 modulates metabolic reprogramming to affect 5-FU resistance and cell pyroptosis in colorectal cancer. Cancer Nanotechnol. 2024;15(1):23.","journal-title":"Cancer Nanotechnol"},{"key":"4444_CR237","first-page":"299","volume":"11","author":"D Desai","year":"2016","unstructured":"Desai D, Prabhakar N, Mamaeva V, Karaman D, L\u00e4hdeniemi IA, Sahlgren C, et al. Targeted modulation of cell differentiation in distinct regions of the gastrointestinal tract via oral administration of differently PEG-PEI functionalized mesoporous silica nanoparticles. Int J Nanomed. 2016;11:299\u2013313.","journal-title":"Int J Nanomed"},{"issue":"1","key":"4444_CR238","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12672-025-01846-3","volume":"16","author":"EM Ragab","year":"2025","unstructured":"Ragab EM, Gamal DME, El-Najjar FF, Elkomy HA, Ragab MA, Elantary MA, et al. New insights into Notch signaling as a crucial pathway of pancreatic cancer stem cell behavior by chrysin-polylactic acid-based nanocomposite. Discov Oncol. 2025;16(1):107.","journal-title":"Discov Oncol"},{"issue":"12","key":"4444_CR239","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.1021\/acs.molpharmaceut.4c00801","volume":"21","author":"ST Nair","year":"2024","unstructured":"Nair ST, Abhi C, Kamalasanan K, Pavithran K, Unni AR, Sithara MS, et al. Pathophysiology-Driven Approaches for Overcoming Nanomedicine Resistance in Pancreatic Cancer. Mol Pharm. 2024;21(12):5960\u201388.","journal-title":"Mol Pharm"},{"issue":"7","key":"4444_CR240","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1080\/14712598.2020.1738377","volume":"20","author":"VW Xue","year":"2020","unstructured":"Xue VW, Wong SC, Song C G, and, Cho WCS. Promising RNA-based cancer gene therapy using extracellular vesicles for drug delivery. Expert Opin Biol Ther. 2020;20(7):767\u201377.","journal-title":"Expert Opin Biol Ther"},{"issue":"9","key":"4444_CR241","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1016\/j.ymthe.2024.02.025","volume":"32","author":"M Muskan","year":"2024","unstructured":"Muskan M, Abeysinghe P, Cecchin R, Branscome H, Morris KV, Kashanchi F. Therapeutic potential of RNA-enriched extracellular vesicles: The next generation in RNA delivery via biogenic nanoparticles. Mol Ther. 2024;32(9):2939\u201349.","journal-title":"Mol Ther"},{"issue":"5","key":"4444_CR242","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.stem.2022.04.011","volume":"29","author":"FJM Roos","year":"2022","unstructured":"Roos FJM, van Tienderen GS, Wu H, Bordeu I, Vinke D, Albarinos LM, et al. Human branching cholangiocyte organoids recapitulate functional bile duct formation. Cell Stem Cell. 2022;29(5):776\u2013e794713.","journal-title":"Cell Stem Cell"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04444-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04444-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04444-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:02:47Z","timestamp":1790096567000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04444-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":242,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4444"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04444-7","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"23 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"325"}}